Suchergebnisse - "Hsu, Ann"

PubPharm (12)

1

Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease

enthalten in: Journal of the neurological sciences | 2017

von Tetrud, J. | Nausieda, P. | Kreitzman, D. | +11

2

Clinical Pharmacokinetics of IPX066 : Evaluation of Dose Proportionality and Effect of Food in Healthy Volunteers

enthalten in: Clinical neuropharmacology | 2016

von Yao, H. | Hsu, A. | Gupta, S. | +1

3

Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®))

enthalten in: Journal of clinical pharmacology | 2015

von Hsu, A. | Yao, H. | Gupta, S. | +1

4

Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease : A 9-Month Open-Label Extension Trial

enthalten in: CNS drugs | 2015

von Waters, C. | Nausieda, P. | Dzyak, L. | +8

5

Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease : Experience in Clinical Trials

enthalten in: Journal of Parkinson's disease | 2015

von Nausieda, P. | Hsu, A. | Elmer, L. | +8

6

Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients

enthalten in: Parkinsonism & related disorders | 2014

von Stocchi, F. | Hsu, A. | Khanna, S. | +7

7

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease

enthalten in: Parkinsonism & related disorders | 2014

von Pahwa, R. | Lyons, K. | Hauser, R. | +64

8

Population pharmacodynamics of IPX066 : an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease

enthalten in: Journal of clinical pharmacology | 2013

von Mao, Z. | Hsu, A. | Gupta, S. | +1

9

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2011

von Hauser, R. | Ellenbogen, A. | Metman, L. | +6

CommentIn: Mov Disord. 2012 Apr;27(4):579. - PMID 22344707

10

Reducing dosing frequency of carbidopa/levodopa : double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients

enthalten in: Clinical neuropharmacology | 2009

von Hinson, V. | Goetz, C. | Leurgans, S. | +3